4//SEC Filing
Celldex Therapeutics, Inc. 4
Accession 0001179110-15-009610
$CLDXCIK 0000744218operating
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 3:06 PM ET
Size
5.5 KB
Accession
0001179110-15-009610
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option
2015-06-10+116,500→ 116,500 totalExercise: $25.41From: 2016-06-10Exp: 2025-06-10→ Common Stock (116,500 underlying)
Footnotes (1)
- [F1]25% vest on June 10, 2016 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000744218
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 3:06 PM ET
- Size
- 5.5 KB